Home > Market Research > Prescription Medicines > The Pharmaceutical Market: Colombia

Table of Contents

Management Report
Published: January 2010
Pages: 56
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00   Buy Now!
Research from: Espicom
Sector: Prescription Medicines

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

The Colombian pharmaceutical market is the fifth largest in Latin America. The majority of the market is supplied by the relatively well-developed domestic industry. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments fo

According to the Economist Intelligence Unit (EIU), the popularity of the President, Álvaro Uribe, remains high. He is expected to be able to continue in power, if he is allowed to run in the presidential elections running in May 2010. The country has felt some effects from the current global credit crisis, but GDP is expected to grow by 2.4% in real terms in 2010. Demographically, the country has the third largest population in Latin America, which is an attractive market, but those aged 65 and over only represent 5.8% of the total. Legally, an argument between the White House and Congress stopped a TPA agreement between the USA and Colombia being fast-tracked, which might have enforced IP regulations, perhaps delaying it indefinitely.

The Colombian pharmaceutical market is the fifth largest in the region. The economic recovery is expected to slightly encourage expenditure on health and insurance, therefore the market will increase by a moderate CAGR at retail prices between 2010 and 2015. In the retail pharmacy sector, POM and OTC medicines maintain a similar market share compared to previous years. Pharmaceutical imports and exports are expected to rise due to an increasing demand for pharmaceuticals. Market fragmentation continues due to the high number of pharmaceutical companies operating in the market. Increasing gross pharmaceutical production is expected to create more jobs.

The majority of the market is supplied by the relatively well-developed domestic industry. Despite having this, the country consistently runs a negative balance of trade in pharmaceuticals. Imports of both raw materials and finished medicaments have increased in recent years, with a particularly high import growth for raw materials. The major pharmaceutical producers are subsidiaries of international companies, but only a few are left. The largest indigenous manufacturers are Bussié, Genfar, Lafrancol, La Santé, Procaps and Tecnoquímicas which produce generic copycats. Tecnoquimicas announced the purchase of the largest pharmaceutical laboratory in El Salvador, Teramed, in October 2009, for the sum of US$30 million, as part of a Central American expansion plan.

Highly detailed report content

MARKET OUTLOOK
Key national data projections

Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development

Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property

Pharmaceutical distribution

Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel

Top of Page

Table of Contents

EXECUTIVE SUMMARY 1
Pharmaceutical Market Analysis . 3
Size . 3
Market Structure . 4
Pharmacy Sector . 4
Generics Sector . 4
OTC Sector 5
Public Sector . 5
Projections & Outlook . 5
Imports 9
Domestic Manufacturing . 12
Domestic Production . 12
Trade Associations 13
AFIDRO . 13
ANDI 13
ASINFAR . 13
CECIF 13
Local Manufacturers 15
America . 15
Biogen . 15
Beiersdorf 15
California . 15
Ecar . 15
Fabrifarma . 16
Genfar 16
Grupo Ave . 16
Lafrancol 16
La Santé 17
Procaps . 17
Tecnoquímicas 18
Multinational Manufacturers 19
Baxter 19
Bayer Schering 19
Boehringer Ingelheim 19
Bristol-Myers Squibb . 20
GlaxoSmithKline 20
Merck . 20
COLOMBIA PHARMA OUTLOOK
Pharma Outlook espicom BUSINESS INTELLIGENCE
ii Quarter I 2010
sanofi-aventis 20
Schering Plough 20
Exports 21
Research & Development . 23
Bogotá Destination for Phase II-IV Drug trials 23
Pharmaceutical Regulatory Analysis 24
Pharmaceutical Regulation . 24
Pharmaceutical Registration . 24
New Drugs 25
Modifications . 26
Renewals 26
Biologic Products 26
Product Control & Vigilance 26
Import Certification 27
Advertising 27
Patent Protection & Intellectual Property Rights 28
Pricing & Reimbursement . 29
Drug Pricing . 29
Reimbursement . 31
Pharmaceutical Distribution 33
Wholesaling . 33
Retailing . 33
Healthcare Analysis 34
Demographics . 34
Population . 34
Birth Rate . 35
Death Rate 35
Infant Mortality . 35
Life Expectancy at Birth . 35
Public Health . 35
Causes of death 35
Incidence of Communicable Disease . 35
Incidence of Non-communicable disease . 35
Tuberculosis 36
HIV/AIDS . 36
Healthcare System 37
Universal Health Insurance . 38
Financial Problems 39
Inter-American Development Bank Social Security Projects 39
PHARMA OUTLOOK COLOMBIA
Pharma Outlook espicom BUSINESS INTELLIGENCE
Quarter I 2010 iii
Health Expenditure . 40
Health Expenditure Projections . 40
Healthcare Infrastructure 41
Inpatient Analysis 41
Inter-American Development Bank Hospital Programme . 41
Healthcare Personnel . 42
Physician Projections 42
DIRECTORY 43
Government Organisations . 43
Trade Associations . 43
Methodology & Sources . 44
List of Tables
Summary of Key Data Projections, 2010-2015 . 2
Pharmaceutical Market, 2010 . 3
Pharmaceutical Market, 2000-2007 (%) . 4
Pharmacy Sector by Type, 2005-2007 (%) 4
Market Projections, 2010-2015 . 5
SWOT Analysis of the Colombian Pharmaceutical Market, 2010 . 6
Espicom Analysis of the Colombian Pharmaceutical Market, 2010 . 7
Imports of Pharmaceuticals by Category, 2003-2007 (US$000s) 9
Import Trends, 2007 (US$000s) . 9
Leading Suppliers of Raw Materials, 2007 (US$000s) . 10
Leading Suppliers of Medicaments, 2007 (US$000s) 11
Pharmaceutical Production Indicators, 2000-2006 12
AFIDRO Members, 2009 . 13
CECIF members, 2009 14
Boehringer Ingelheim’s Net Sales, 2004-2006 19
Exports of Pharmaceuticals, 2003-2007 (US$000s) . 21
Export Trends, 2007 (US$000s) . 21
Leading Destinations, 2007 (US$000s) . 22
Summary of the USA - Colombian Trade Agreement’s Intellectual Property Agreements, 2006 28
Drug Pricing Classification, 2005 29
Drug Pricing Classification I, 2005 (%) 29
Drug Pricing Classification II, 2005 (%) . 30
Projected Population, 2010-2015 . 34
COLOMBIA PHARMA OUTLOOK
Pharma Outlook espicom BUSINESS INTELLIGENCE
iv Quarter I 2010
Summary Demographic Data, 2005/2007 34
Entities within the Ministry of Social Protection, 2004 37
Healthcare Expenditure, 2006 40
Projected Health Expenditure, 2010-2015 . 40
Hospitals & Beds, 2004 . 41
Projected Number of Physicians, 2010-2015 42
List of Charts
Pharmaceutical Market, 2000-2005 3
Radar Graph of the Colombian Pharmaceutical Market, 2010 8
Imports by Category, 2007 (%) 9
Leading Suppliers, 2007 (%) 10
Leading Destinations, 2007 (%) . 22
Distribution of the Population by Type of Coverage, 2005 . 38

For full details, please email keithw@cmsinfo.com

Top of Page

Buy now!

PDF single user

 GBP 595.00   

Paper

 GBP 595.00   

Online Access

 GBP 595.00   

Your personal guarantee

Top of Page